Greg Troiano

Greg Troiano is the Chief Manufacturing Officer at mRNA CoE, Sanofi, Inc., since May 2020, overseeing strategic operations related to CMC, cGMP supply, quality, and engineering. Troiano has extensive experience in the pharmaceutical industry, previously serving as Vice President of Nanomedicine Development & Manufacturing at Pfizer, where focus areas included nanoparticle drug product development and complex formulations. Additionally, Troiano held senior leadership positions at BIND Therapeutics, where responsibilities included directing the development of ACCURIN candidates, and has also contributed as an instructor in various health clubs. Troiano's foundational experience includes roles at Alkermes and Guilford Pharmaceuticals, with a strong technical background supported by a Master's degree in Biomedical and Chemical Engineering from The Johns Hopkins University.